Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / RHHBY - Affimed: Remaining Bullish Despite Study Discontinuation

RHHBY - Affimed: Remaining Bullish Despite Study Discontinuation

Roche Holding Ltd ADR
  • Affimed recently reported their Q1 earnings that revealed a solid beat on EPS and revenue. However, the company also announced that Genentech has stopped one of their partnered programs.
  • Following the Genentech announcement, the share price has been under pressure. I believe the market is overreacting, which could provide an opportunity to buy.
  • I discuss the impact of the discontinuation and will defend my bullish outlook.
  • Finally, I take a look at the charts to find a few opportunities to add to my "house money" position.

For further details see:

Affimed: Remaining Bullish Despite Study Discontinuation
Stock Information
Company Name: Roche Holding Ltd ADR
Stock Symbol: RHHBY
Market: OTC
Website: roche.com
Menu
RHHBY RHHBY Quote RHHBY Short RHHBY News RHHBY Articles RHHBY Message Board
Get RHHBY Alerts

News, Short Squeeze, Breakout and More Instantly...